Director/Senior Director, Corporate Development & Communications

Todd & Weld, LLP; Cambridge (MA); On-site; USD 150,000 - 250,000; Full time

Job summary

A leading biopharmaceutical company in Cambridge, Massachusetts is seeking a Senior Leader for Business Development and Investor Relations. This role requires deep expertise in the biotech sector, strategic negotiation skills, and the ability to communicate complex concepts clearly. The ideal candidate will enhance company partnerships and investor relations while driving early-stage product strategies in a mission-driven environment.

Benefits

Competitive compensation including equity

Comprehensive benefits package

401(k) retirement plan

Company-funded health savings account

Free parking

Qualifications

• 10+ years in biotech/pharma, with at least 5 years in senior roles.
• Experience closing licensing deals and managing investor relations.
• Expertise in financial modeling and SEC filings.

Responsibilities

• Identify and execute strategic partnerships and M&A opportunities.
• Lead negotiations and collaborate with R&D and finance teams.
• Serve as liaison for institutional investors and maintain investor messaging.

Skills

Financial Modeling

Scientific Understanding

Deal-Making Expertise

Market Research

Education

Bachelor's degree in life sciences

Advanced degree (MS, MBA, PhD, MD)

Job description

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro's lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts.

We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.

Position Summary:

This senior leadership role integrates three critical functions: Business Development, Investor Relations, and Early Commercial Assessment. The ideal candidate will drive strategic partnerships, communicate the company's value proposition to investors, and evaluate commercial viability of early-stage pipeline assets. While experience across all three domains is valuable, we welcome candidates with strengths in one or more areas who are eager to collaborate cross-functionally and grow into the broader scope of the role. A blend of financial acumen, scientific understanding, and deal-making expertise in the biotech/pharma sector will be important for success.

Key Responsibilities:

• Identify, evaluate, and execute strategic partnerships, licensing deals, and M&A opportunities to expand the company's pipeline and market reach.
• Lead negotiations with biotech, pharma, and academic institutions, including term-sheet drafting, financial modeling, and due diligence.
• Collaborate with R&D, legal, and finance teams to structure transactions aligned with corporate goals.
• Serve as the primary liaison for institutional investors, sell-side analysts, and financial media, ensuring consistent and transparent communication.
• Develop and maintain investor messaging materials (earnings scripts, presentations, Q&A) and manage quarterly earnings processes.
• Draft, review, and coordinate the release of press releases, ensuring accuracy and compliance with regulatory requirements.
• Oversee the company's corporate website and investor relations portal, ensuring timely updates of financial reports, press releases, and key company milestones.
• Manage relationships with PR agencies and external communications partners as needed.
• Monitor media coverage, industry news, and investor sentiment to inform leadership and shape communication strategy.
• Ensure all public communications (including web and social media content) align with company branding, legal, and regulatory standards.
• Analyze market trends, competitor activity, and investor sentiment to inform leadership.
• Conduct market research and advisory boards to assess commercial potential of preclinical/clinical assets.
• Build financial models to evaluate market size, pricing, and reimbursement scenarios for pipeline candidates.
• Collaborate with clinical and regulatory teams to align development plans with commercial strategies.

Required Qualifications:

• Bachelor's degree in life sciences; advanced degree (MS, MBA, PhD, MD) preferred.
• 10+ years in biotech/pharma, with at least 5 years in senior roles spanning business development, investor relations, and/or early product strategy.
• Experience closing licensing deals, partnerships, or M&A transactions.
• Experience or familiarity with biotech deal structures including milestone payments, royalty tiers, and co-development arrangements.
• Experience managing investor relations for a publicly traded biotech company.
• Participation in or exposure to investor communications during clinical trial results, FDA interactions, or key regulatory events.
• Expertise in financial modeling, valuation methodologies, and SEC filings.
• Strong ability to translate complex scientific data into clear, investor-friendly narratives that effectively convey the company's vision, scientific progress, and overall value proposition.
• Proficiency in market research tools and competitive intelligence.
• Awareness of biotech intellectual property considerations such as composition of matter, method of use, and formulation patents.
• Established relationships with institutional investors, venture capital firms, and biotech executives is preferred.
• Familiarity with global regulatory and reimbursement landscapes.
• Exposure to breakthrough therapy designations, orphan drug pathways, and accelerated approval processes.
• Ability to travel in alignment with organizational and business need.

Benefits: Korro offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance, a dependent care flexible spending account and a Company-funded health savings account and free parking.